Home › IGA Glomerulonephritis › South Dakota
IGA Glomerulonephritis clinical trials in South Dakota
4 studies for IGA Glomerulonephritis are looking for participants at sites in South Dakota.
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- ADARx Clinical Site, Dakota Dunes
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06989359Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Dunes Clinical Research, Dakota Dunes
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135Study of BHV-1400 in IgA Nephropathy
- Site-002, Dakota Dunes
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
- Clinical Research Site 374, Dakota Dunes
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Apr 6, 2025 · NCT06740526From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.